Five-day versus ten-day treatment of acute otitis media with cefprozil

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 4, 1997, Pages 283-286

  Kafetzis, D A ^a   Astra, H ^a   Mitropoulos, L ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFPROZIL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE;

EID: 0030938208     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01695632     Document Type: Article

References (13)

1. Bass JW, Cashman TM, Frostad AL, Yamaoka RM, Schooler RA, Dierdorff EP: Antimicrobials in the treatment of acute otitis media. A second clinical trial. American Journal of Diseases of Children 1973, 125: 397-403.
2. Strickler GB, McBean JB: The treatment of acute otitis media in children. II: A second clinical trial. Journal of the American Medical Association 1964, 187: 85-89.
3. van Buchem PL, Dunk JHM, van't Hof MA: Therapy of acute otitis media: myringotomy, antibiotics or neither? Lancet 1981, ii: 883-887.
4. Meistrup-Larsen KI, Sorensen H, Johnsen NJ, Thomsen J, Mygind N, Sedrberg-Olsen J: Two versus seven days penicillin treatment for acute otitis media. Acta Otolaryngologica 1983, 96: 99-104.
5. Chaput de Saintonge DM, Levine DF, Templae Savage I, Burgess GWS, Sharp J, Mayhew SR, Salder MG, Moody R, Griffiths R, Griffiths S, Meadows G: Trial of three-day and ten-day courses of amoxycillin in otitis media. British Medical Journal 1982, 284: 1078-1081.
6. Hendrickse WA, Kusmiesz H, Shelton S, Nelson JD: Five versus ten days of therapy for acute otitis media. Pediatrie Infectious Disease Journal 1988, 7: 14-23.
7. Aldrige KE, Shiro DD, Sanders CV: Comparative in vitro activity of the new oral cephalosporin BMY-28100. European Journal of Clinical Microbiology 1987, 6: 170-172.
8. Scribner RK, Marks MI, Finkhouse BD: In vitro activity of BMY-28100 against common bacteria isolated from pediatric infections. Antimicrobial Agents and Chemotherapy 1987, 31: 630-631.
9. Kafetzis DA: Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media. European Journal of Clinical Microbiology & Infectious Diseases 1994, 13: 857-865.
10. Mandel EM, Bluestone CD, Rockette HE, Blatter MM, Reisinger KS, Wucher FP, Harper J: Duration of effusion after antibiotic treatment for acute otitis media: comparison of cefaclor and amoxicillin. Pediatric Infectious Disease Journal 1982, 1: 310-316.
11. Del Beccaro MA, Mendelman PM, Inglis AF, Richardson MA, Duncan NO, Clausen CR, Stull FL: Bacteriology of acute otitis media: a new perspective. Journal of Pediatrics 1992, 120: 81-84.
12. Bluestone CD, Stephenson JS, Martin LM: Ten-year review of otitis media pathogens. Pediatric Infectious Diseases Journal 1992, 11, Supplement: 7-11.
13. Coles SJ, Addlestone MB, Kamdar MK, Macklin JL: A comparative study of clarithromycin and amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Infection 1993, 21 Supplement 4: 272-278.